The Intel-backed healthcare analytics technology provider has closed a new round with investments from AllegisNL Capital and Blue Venture Fund.
Lumiata, a US-based provider of healthcare analytics technology, has raised $14m to close a series B round co-led by AllegisNL Capital, a joint venture between insurance provider Nippon Life and venture capital firm Allegis Capital.
VC firm Defy.vc co-led the round, which included Blue Venture Fund, a corporate venturing fund that represents 36 BlueCross BlueShield health insurers, and VC firm Khosla Ventures.
Founded in 2013, Lumiata has developed a data analytics software platform that uses artificial intelligence and machine learning…
